Searched for
TAKEDA
Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....05 Aug, 2026, 10.03 AM IST- Karnataka discusses Takeda GCC expansion, innovation partnershipsKarnataka held discussions with Takeda Pharmaceutical leaders regarding their global capability center expansion. The talks focused on digi...29 Jul, 2026, 08.14 PM IST
- Alembic Pharma gets USFDA approval for generic chronic constipation treatment tabletsAlembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of...28 Jul, 2026, 03.46 PM IST
- Quote of the day by Takeda Shingen: 'Knowledge is not power, it is only potential. Applying that knowledge is...' - motivational quote by Japanese samurai and Tiger of Kai teaches why knowledge is useless until you know how to use it and why the smartest person may not be the wisestQuote of the day by Takeda Shingen: Takeda Shingen's quote highlights knowledge as potential, with application being power. True wisdom inv...22 Jul, 2026, 01.48 PM IST
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...21 Jul, 2026, 07.07 AM IST
- Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...20 Jul, 2026, 11.21 AM IST
- Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...02 May, 2025, 01.22 PM IST
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentThe Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and cybersecurity experts,...15 Jan, 2025, 09.24 PM IST
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentTakeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurit...15 Jan, 2025, 08.54 PM IST
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...21 Jun, 2024, 10.57 AM IST
- Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...29 Feb, 2024, 11.52 PM IST
- Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccineJapanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...27 Feb, 2024, 11.16 AM IST
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...17 Dec, 2012, 09.51 PM IST
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...24 Aug, 2011, 11.06 AM IST
- Japan's Takeda eyes Lupin, Cipla pharma businessTakeda, Japan's largest pharmaceutical firm, has begun talks with two of India's biggest companies for purchasing either of their pharma bu...24 Aug, 2011, 06.24 AM IST
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...15 Mar, 2010, 03.10 PM IST
- Japan's Takeda in $8.8 billion bid for US biotech firmJapan's Takeda Pharmaceutical Co has agreed to pay about $8.8 billion for US biotech company Millennium Pharmaceuticals Inc, the two firms ...10 Apr, 2008, 02.12 PM IST
Load More
